AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28792105
Drug: TPTNS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPTNS plus 20 mg trospium chloride daily
Trial: 26807631
Drug: Intravitreal injections
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injections of rtPA, perfluoropropane (C3F8) gas, and bevacizumab (n = 12)
Trial: 26807631
Drug: Vitrectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitrectomy with subretinal rtPA administration, intravitreal C3F8 gas, and bevacizumab (n = 12)
Trial: 21198965
Drug: High biotin
RxNorm normalized name: Biotin
DrugBank: Biotin (DB00121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High biotin diet (2000 μg/kg)
Trial: 21198965
Drug: High Zn
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Zn diet (150 mg/kg)
Trial: 21198965
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (300 μg biotin and 50 mg Zn/kg)
Trial: 21198965
Drug: Wet litter
RxNorm normalized name: BITTER MELON
DrugBank: Momordica charantia fruit (DB14265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wet litter exposure (27% DM for 8 h daily)
Trial: 21135293
Drug: Metoprolol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (1 to 3 mg/h for 48 hours)
Trial: 21135293
Drug: Amiodarone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (15 mg/kg daily, max 1000 mg for 48 hours)
Trial: 16301237
Drug: Spinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal block with 5 mg of 0.5% bupivacaine (LDS)
Trial: 16301237
Drug: Spinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal block with 2.5 mg of 0.5% bupivacaine plus 25 mug of fentanyl (SDS)
Trial: 16301237
Drug: Spinal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal block with 2.5 mg of bupivacaine plus 25 mug of fentanyl (SDS)
Trial: 7621007
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with ischemic cardiopathy (no calcium antagonists)
Trial: 2658574
Drug: No empiric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No empiric antifungal therapy (control)
Trial: 5302329
Drug: High-potency whole-cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency whole-cell cholera vaccine
Trial: 23362293
Drug: Cholera vaccine
RxNorm normalized name: Cholera Vaccine
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholera vaccine
Trial: 31043161
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of plant sterols (PS) and omega‐3 fatty acids
Trial: 31043161
Drug: Placebo (soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (soy bean powder plus placebo capsules)
Trial: 27749740
Drug: Pueraria mirifica
RxNorm normalized name: PUERARIA MIRIFICA ROOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pueraria mirifica gel
Trial: 27749740
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen cream (CEE)
Trial: 12548439
Drug: Anti-inflammatory diet
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-inflammatory diet (AID) with arachidonic acid intake of less than 90 mg/day
Trial: 12548439
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules (30 mg/kg body weight)
Trial: 1848385
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Logiparin)
Trial: 6472365
Drug: Acetohydroxamic acid
RxNorm normalized name: Acetohydroxamic Acid
DrugBank: Acetohydroxamic acid (DB00551)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetohydroxamic acid (15 mg per kilogram of body weight per day, in divided oral doses)
Trial: 17175820
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg every 8 hours)
Trial: 27384376
Drug: Acetaminophen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1 g every 6 hours)
Trial: 27384376
Drug: Both Ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Both Ibuprofen and Acetaminophen
Trial: 25717250
Drug: LC+IOC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC+IOC treatment
Trial: 25717250
Drug: Routine LC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine LC treatment
Trial: 23981814
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of inositol and alpha lipoic acid
Trial: 17708158
Drug: Cold blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold blood cardioplegia solution with Technetium (Tc-99m) tracer
Trial: 17708158
Drug: Cold blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold blood cardioplegia solution
Trial: 15113965
Drug: Daily supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supervised iron supplementation [3-6 mg/(kg.d)]
Trial: 15113965
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly supervised iron supplementation [6-12 mg/(kg.wk)]
Trial: 15113965
Drug: Daily unsupervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily unsupervised iron supplementation
Trial: 15113965
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly unsupervised iron supplementation
Trial: 9701417
Drug: Orciprenaline sulphate
RxNorm normalized name: orciprenaline
DrugBank: Orciprenaline (DB00816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orciprenaline sulphate (2.25 mg)
Trial: 7838917
Drug: Flumazenil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (2 mg in saline)
Trial: 3171331
Drug: Topical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prostaglandin E2 (0.02% solution)
Trial: 3171331
Drug: Topical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prostaglandin E2
Trial: 25569624
Drug: Skimmed milk
RxNorm normalized name: Calcium fortified skimmed milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skimmed milk (600 mL)
Trial: 25569624
Drug: Orange drink
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange drink (600 mL)
Trial: 24660603
Drug: Chinese medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medication (established Chinese herbal formulas)
Trial: 24660603
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (leukotriene receptor antagonist and bronchial relaxant)
Trial: 18483475
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA)
Trial: 18483475
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA) plus reduced energy density eating (REDE)
Trial: 9374583
Drug: vapocoolant spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vapocoolant spray + distraction
Trial: 9374583
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream + distraction
Trial: 8247189
Drug: Prednisone 60
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone 60 mg/day
Trial: 3033180
Drug: enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril 20 mg daily
Trial: 12107602
Drug: atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50 mg daily
Trial: 3033180
Drug: enalapril (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (higher dose if diastolic BP > 90 mmHg)
Trial: 3033180
Drug: atenolol (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (higher dose if diastolic BP > 90 mmHg)
Trial: 29923305
Drug: LI85008F (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LI85008F (900 mg/d in two divided doses)
Trial: 24225560
Drug: L-arginine (ARG)
DrugBank: L-arginine (DB17289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (ARG)
Trial: 25380894
Drug: Other formulations
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other formulations of mycophenolate
Trial: 17852173
Drug: Internet-based cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive-behavioral therapy for complicated grief
Trial: 16046981
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L PEG‐E with a regular diet the day before colonoscopy followed by another 2 L PEG‐E on the day of the procedure (Group B)
Trial: 16046981
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L PEG‐E with a liquid diet the day before colonoscopy (Group A)
Trial: 10588465
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (daily intake: 216 mg eicosapentaenoic acid, 140 mg docosahexaenoic acid, 390 mg gamma‐linolenic acid, and 3480 mg linoleic acid)
Trial: 8466726
Drug: Isradipine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 1.25 mg twice daily
Trial: 1673616
Drug: Isradipine combined
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine combined with 1 mg/day bopindolol
Trial: 7282610
Drug: Increasing amounts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing amounts of carbohydrate (88 to 648 g carbohydrate/day)
Trial: 31971089
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (4000 IU of Vit D3 daily for 4 weeks)
Trial: 29260292
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (4000 IU daily for 3 years)
Trial: 23018287
Drug: Metronome sound-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronome sound-guided group (MG)
Trial: 16673797
Drug: Metronidazole cream
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole cream (0.75% and 1%)
Trial: 16673797
Drug: Metronidazole gel
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole gel (0.75% and 1%)
Trial: 16673797
Drug: Metronidazole lotion
RxNorm normalized name: metronidazole Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole lotion (0.75% and 1%)
Trial: 7631329
Drug: Active blood
RxNorm normalized name: Accu-Chek Active Blood Glucose Meter Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active blood pressure treatment
Trial: 2115856
Drug: 80 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 micrograms intravenous GHRH
Trial: 7308953
Drug: Indomethacin retard,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin retard, applied twice daily (43% of cases) or sometimes (14%)
Trial: 29596010
Drug: Higher intensity
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher intensity whole body vibration (amplitude 8.82 mm, g force 2.76)
Trial: 29596010
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity whole body vibration (amplitude 4.53 mm, g force 2.21)
Trial: 30591069
Drug: Brief medication
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief medication review combined with a standardised communication strategy at hospital discharge
Trial: 19366435
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration
Trial: 28922968
Drug: N-acetylcysteine (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (2400 mg)
Trial: 22549117
Drug: No compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No compound (control)
Trial: 19027366
Drug: Oestrogen/progestin hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen/progestin hormone therapy
Trial: 19027366
Drug: Selective oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective oestrogen receptor modulators
Trial: 11863154
Drug: 4.4 ml
RxNorm normalized name: APONVIE 32 MG in 4.4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.4 ml lidocaine with 1:80,000 epinephrine
Trial: 11863154
Drug: 4.4 ml
RxNorm normalized name: APONVIE 32 MG in 4.4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.4 ml 3% prilocaine with 0.031 U/ml felypressin
Trial: 10445367
Drug: NaF gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaF gel (1%)
Trial: 10445367
Drug: SnF2 gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SnF2 gel (1%)
Trial: 3668844
Drug: Diazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (20 mg)
Trial: 31652344
Drug: Zolpidem hemitartrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem hemitartrate formulation (5 mg orodispersible tablet)
Trial: 31652344
Drug: Zolpidem hemitartrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem hemitartrate formulation (5 mg sublingual tablet)
Trial: 8378946
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg/d
Trial: 23915042
Drug: Placebo analgesic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo analgesic treatments (choice between treatments)
Trial: 23915042
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (choice of treatment)
Trial: 23915042
Drug: Auditory discomfort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auditory discomfort paradigm (choice between treatments)
Trial: 20689466
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestogen therapy
Trial: 19298337
Drug: 14-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 14-day regimen with 500 mg clarithromycin b.i.d., 500 mg metronidazole t.i.d., and 500 mg amoxicillin t.i.d.
Trial: 19298337
Drug: 10-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 10-day regimen containing 500 mg clarithromycin b.i.d., 1 g amoxicillin b.i.d., and 20 mg omeprazole b.i.d.
Trial: 19298337
Drug: 14-day clarithromycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day clarithromycin, metronidazole, and amoxicillin regimen
Trial: 19298337
Drug: 10-day clarithromycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day clarithromycin, amoxicillin, and omeprazole regimen
Trial: 19298337
Drug: Participants with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participants with atrophic gastritis receiving clarithromycin, metronidazole, and amoxicillin
Trial: 19298337
Drug: Participants with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participants with atrophic gastritis receiving clarithromycin, amoxicillin, and omeprazole
Trial: 9519749
Drug: Picotamide, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide, 300 mg, 3 tablets/day
Trial: 9519749
Drug: Placebo, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 3 tablets/day
Trial: 2699544
Drug: Kanamicine sulphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kanamicine sulphate daily for 6 days followed by polidesossiribonucleotide for 24 days
Trial: 26635079
Drug: 16 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 g/d prebiotic supplementation
Trial: 23605175
Drug: Mindfulness intervention
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mindfulness intervention (eight weekly individual phone sessions)
Trial: 14669032
Drug: Therapy (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy (not specified)
Trial: 8952010
Drug: Vigabatrin 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigabatrin 3 g/day
Trial: 1893304
Drug: Prazosin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (10 mg bid, titrated to 18.6 +/- 0.7 mg/day)
Trial: 6407410
Drug: Weekly exchange
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly exchange of CVC via a guidewire
Trial: 25645091
Drug: Oxalobacter formigenes
RxNorm normalized name: Oxalobacter formigenes
DrugBank: Oxabact (DB17676)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxalobacter formigenes (700 million, twice a day)
Trial: 25645091
Drug: Potassium magnesium
RxNorm normalized name: POTASSIUM MAGNESIUM SULFATE
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium magnesium citrate (30 mEq, twice a day)
Trial: 23539907
Drug: Candesartan 8
RxNorm normalized name: candesartan 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8 mg/16 mg as add-on therapy to ACE-inhibitors
Trial: 20592724
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg
Trial: 19011428
Drug: Ziprasidone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone (40 mg single dose)
Trial: 19011428
Drug: Haloperidol (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (7.5 mg single dose)
Trial: 19011428
Drug: Ziprasidone (steady-state
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone (steady-state treatment)
Trial: 12745490
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray alone
Trial: 12745490
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (nicotine patch + nicotine nasal spray)
Trial: 12745490
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch alone, Nicotine nasal spray alone, Combination therapy
Trial: 8627439
Drug: Preservative-free topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free topical ointment therapy
Trial: 8627439
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no topical treatment or as-needed therapy with a water-in-oil emollient)
Trial: 2741976
Drug: Propranolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.1 mg/kg intravenously)
Trial: 3922732
Drug: Metoprolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (0.15 mg/kg intravenously)
Trial: 29316164
Drug: Exenatide once
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide once weekly plus dapagliflozin
Trial: 27391640
Drug: Once-daily 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily 5% minoxidil topical foam (MTF)
Trial: 27391640
Drug: Twice-daily 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-daily 2% minoxidil topical solution (MTS)
Trial: 24641892
Drug: DepoDur (extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DepoDur (extended-release epidural morphine)
Trial: 23310938
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg propofol (PG)
Trial: 23310938
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg thiopentone (TG)
Trial: 16867927
Drug: Slow-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release morphine
Trial: 24140630
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg per day
Trial: 1592970
Drug: Dentifrice with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentifrice with 1000 micrograms F/g
Trial: 1592970
Drug: Dentifrice with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentifrice with 1500 micrograms F/g